London Daily

Focus on the big picture.
Monday, Oct 05, 2026

Omicron is coming but boosters should fight it, federal health officials say

Omicron is coming but boosters should fight it, federal health officials say

Federal health officials said Wednesday they are ready for an onslaught of the fast-transmitting Omicron coronavirus variant but said if people get vaccinated and boosted they should be all right.

There's no need for variant-specific vaccines, they said, while hedging on the question of redefining what it means to be fully vaccinated, saying instead that Americans should get booster shots because it's the sensible thing to do.

And they noted that the Delta variant is wreaking plenty of havoc on its own. The US Centers for Disease Control and Prevention predicted an increase in the rate of deaths from Covid-19 over the coming weeks. It projected between 837,000 and 845,000 people will have died by January 8.

An average of close to 120,000 new Covid-19 cases are being diagnosed each day, according to data from Johns Hopkins University -- 50% more than a month ago. And more than 1,200 people are dying every day, on average.

"We are already in a Delta surge," Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, told CNN's Wolf Blitzer.

"The cases are going up. We have an average of about 117,000 cases. We have an increase in the percentage of hospitalizations. Deaths are still over a thousand," Fauci said. "Then you have, looking over your shoulder, the Omicron variant, which we know, from what's going on in South Africa and in the UK, is a highly transmissible virus.

"That's the reason why we are encouraging people, if they haven't been vaccinated, to get vaccinated but, as importantly, for those who've been fully vaccinated to get a booster."

There is no doubt Omicron will infect people who have been vaccinated, Fauci said.

'No doubt' about breakthrough infections


"There will be breakthrough infections, no doubt about that," he said.

Asked whether that means the federal government should redefine what it means to be fully vaccinated, Fauci said that does not really matter.

"Well, it's almost a semantic thing for the regulation, as it were," Fauci said. It just makes sense for people to get booster shots, he said.

"We know what optimal is. Optimal is getting a boost. So instead of worrying about what the definition of fully versus not fully is, I'm telling people, if you want to be optimally protected and you're vaccinated, get boosted. That's the message and not worry about a definition," he added.

For now, the federal government considers people to be fully vaccinated if they have received two doses of Moderna's or Pfizer's vaccine, or a single dose of the Johnson & Johnson vaccine -- even with the strong recommendations to add a dose to any of those regimens.

"The definition right now is two doses of an mRNA vaccine or a single dose of the J&J vaccine," US Centers for Disease Control and Prevention Director Dr. Rochelle Walensky told a White House Covid-19 briefing.

More important is getting more people vaccinated, Fauci said.

"The vulnerable people are the people who have not been vaccinated, and I hope that the possibility that we're seeing -- that we're going to be getting a surge of Omicron, which is almost inevitable given its characteristic of high degree of transmissibility," Fauci said. "We have the tools to be able to blunt this. We just need to implement them."

Vaccine makers have said they are working ahead to ready formulations of their vaccines that would specifically protect against the Omicron variant. But Fauci said there's no need for them yet.

"At this point, there is no need for a variant-specific booster," Fauci told the White House briefing Wednesday morning.

Omicron 'freight train is here already'


It's probably too late, anyway, Dr. Peter Hotez, a vaccine specialist and dean of tropical medicine at the Baylor College of Medicine, told CNN's Alisyn Camerota and Victor Blackwell.

"It takes time to make that. They are talking maybe three or four months. This freight train is here already," he said. "It looks like it's going to be here around Christmas so that there's not going to be enough time to really have that booster in place to make a meaningful difference."

Americans are taking the advice to get booster doses to heart, with more than half of the nearly 1.8 million vaccines going into arms each day being booster shots, according to the CDC. Just over 61% of the population is now fully vaccinated and the pace of vaccinations is up 23% over a month ago.

"Across the first two weeks of December, we've gotten 14 million booster shots. That's our highest ever two-week total. So our booster program is accelerating," White House Covid-19 response coordinator Jeff Zients told the White House briefing.

"In looking at early data on transmissibility of Omicron from other countries, we expect to see the proportion of Omicron cases here in the United States continue to grow in the coming weeks," Walensky told the White House briefing. "Early data suggest that Omicron is more transmissible than Delta, with a doubling time of about two days."

But US health officials were keeping a wary eye on Britain, which reported its highest daily number of new coronavirus infections ever Wednesday -- 78,610.
Dr. Jenny Harries, Chief Executive of the UK Health Security Agency, said case numbers will be "quite staggering compared to the rate of growth that we've seen in cases of previous variants."

Omicron evades one Chinese vaccine


More studies indicated that current vaccines will not fully protect people against infection, and one worrying study from researchers in Hong Kong indicated that one of the most widely distributed vaccines, China's Sinovac Covid-19 vaccine doesn't provide sufficient antibodies to protect against the Omicron variant.

The researchers tested samples of Omicron variant virus in blood taken from 25 people who had received both doses of either Sinovac's Coronavac or Pfizer/BioNTech vaccines.

"None of the Coronavac recipients had detectable neutralizing antibody to the Omicron variants," they wrote in a report posted online on the pre-print server MedRxiv. They say it has been accepted for publication in the journal Clinical Infectious Diseases.

Blood taken from people who got the Pfizer/BioNTech vaccine also showed reduced immune response to the Omicron samples, with just 20% to 24% of samples producing sufficient neutralizing antibodies, the study by Kelvin Kai-Wang To and colleagues at the University of Hong Kong found.

And a study from US researchers showed the protection from two doses of Moderna's vaccine wears off, but a booster dose restores much of it -- even against the Omicron variant.

Comments

mike 5 year ago
Pharmaceutical drug dealers are not interested in your health

Newsletter

Related Articles

0:00
0:00
Close
BT Accused of Pressuring Vulnerable Customers During Digital Landline Shift
British Carmakers Warn of Growing Pressure From EU-China Tariff Dispute
Green Party of England and Wales Adopts Motion Defining Zionism as Racism
Medical Charity Threatens NHS Legal Action Over Two-Year Autism and ADHD Assessment Waits
British Transport Police Report Record Rise in Violence on Railways
Glasgow Council Workers Face Pay Cuts Under Fire-and-Rehire Plan
British Medical Groups Press Prime Minister Andy Burnham to Cancel £330 Million Palantir NHS Contract
UK Faces Record Bluetongue Outbreak Across Livestock Farms
UK Schools Report Thousands of Child-on-Child Sexual Offences
High Court Overturns Ban Blocking Gaza Families From Reuniting With Relatives in UK
G7 Authorizes Emergency Fuel Release as UK Diesel Prices Hit £2 a Litre
France and Italy Draw 1-1 in Nations League Match
Pope Leo XIV and Prince Albert II of Monaco Meet in Metz
SNCF Expands Low-Cost Ouigo High-Speed Service Between Lyon and Bordeaux
Paris Expands Dedicated Cargo Bike Routes for Urban Deliveries
French Film Industry Pushes for Tighter Streaming Investment Rules
Marseille Court Hands Down Prison Terms in Public Procurement Corruption Case
LVMH and Kering Rely on US Demand as Chinese Luxury Spending Slows
Toulouse Aerospace Sector Launches €80 Million Modernization Fund
Javier Milei Courts French Investment in LNG and Lithium
Mistral AI Launches Sovereign Model for European Public Services
French Competition Authority Fines Retailers €40 Million Over Misleading Promotions
France Records Exceptional Electricity Exports as Nuclear Output Recovers
Dassault Aviation Expands Rafale Assembly Capacity at Mérignac
Sanofi Invests €1 Billion in New Biologics Production Hub Near Lyon
France Protests Germany’s Extension of Border Controls Into 2027
French Public-Sector and Transport Unions Threaten National Strike
France Deploys Riot Police After Violence in Lyon Suburbs
French Anti-Terrorism Prosecutors Investigate Radicalized Flydubai Co-Pilot
France’s Defense Budget Surpasses NATO’s 2% of GDP Target
French Government Faces No-Confidence Threat Over Budget
France and G7 Release 100 Million Barrels From Strategic Oil Reserves
France Convenes Emergency Defense Council Over Threats to Commercial Shipping
France and Germany Coordinate Military Response After Russian Strikes on Kyiv Infrastructure
UK Police Release Six Iranian Nationals on Bail After RAF Fairford Security Alert
UK Business Confidence Falls as Energy Costs and Tax Uncertainty Rise
Cornwall Insight Warns UK Energy Bills Could Rise 16% in January
UK Introduces Zero VAT on Household Electricity Bills
UK 30-Year Gilt Yield Hits 6% as Bond Market Pressures Intensify
UK Introduces Stricter Subcontractor Checks and Expanded Trade Union Access
Green Party Proposes Three-Year Emergency Freeze on Private Rent Increases
UK Treasury Committee Seeks Tax Clarification Over Manchester City Investigation
Royal Marines Deploy to Faroe Islands for Northern European Security Exercise
UK Business Confidence Weakens as High Costs Delay Investment
UK GDP Growth Revised Up to 0.5% in Second Quarter
Bank of England Warns of Financial Stability Risks From Autonomous AI
UK Expands Early Prisoner Release Scheme to Ease Overcrowding
UK Records Worst Bluetongue Outbreak on Record Across Livestock Farms
UK Government Faces Shrinking Fiscal Headroom Ahead of October 28 Budget
UK 30-Year Gilt Yield Reaches 6% as Energy Shock Drives Borrowing Costs Higher
×